Hausfeld Names Jeannine M. Kenney Partner WASHINGTON,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
70
Hausfeld Names Jeannine M. Kenney Partner

WASHINGTON, Jan. 04, 2017 (GLOBE NEWSWIRE) -- Hausfeld has named Jeannine M. Kenney a partner in the global claimants’ law firm. The firm, headquartered in Washington, DC, has offices in Philadelphia, New York, Boston, San Francisco, London, Berlin, and Brussels.

Ms. Kenney joined the firm in 2009 and works primarily in Hausfeld’s antitrust practice.  She has played a leading role in several of the firm’s antitrust matters, where her efforts have yielded sterling results for class members, including the multi-district litigation in In re Fresh and Process Potatoes Antitrust Litigation (No. 12-md-2186, D. Idaho), which resulted in a global settlement of nearly $20 million with valuable injunctive relief, and In re Processed Egg Products Antitrust Litigation (No. 08-md-2002, E.D. Pa.), in which a litigation class has been certified, plaintiffs’ summary judgment motion eliminated a key defense, and more than $130 million in settlements have been obtained to date.

Ms. Kenney also serves as counsel to the class members in several pending complex antitrust matters, including In re Domestic Airline Travel Antitrust Litigation (No. 15-mc-1401, D.D.C.) and In re Foreign Exchange Benchmark Rates Antitrust Litigation (No. 13-cv-7789, S.D.N.Y.).   In addition to representing plaintiffs in antitrust matters, she represented a defendant in Precision Associates v. Panalpina World Transport (Holding) Ltd., et al. (No.  08-cv-42, E.D.N.Y.), securing a favorable result for the client. Ms. Kenney was recognized as a Super Lawyers Rising Star in Antitrust in Pennsylvania in both 2015 and 2016.

Ms. Kenney has also gained recognition for her skill and expertise in e-discovery, speaking at educational conferences such as the Georgetown University Law Center’s E-discovery Academy, where she has also served as a faculty coach, and its annual Advanced E-discovery Institute, and co-authoring a chapter in the American Bar Association’s recently released Perspectives on Predictive Coding .  Ms. Kenney also advises the firm’s litigation teams in all matters relating to e-discovery. 

Prior to obtaining her juris doctor, Ms. Kenney worked for many years in public policy, serving as a legislative assistant for two U.S. senators and as a consumer advocate with Consumers Union, publisher of Consumer Reports , where she worked in the fields of agriculture, telecommunications, food safety, and financial privacy, among other policy areas.

“Jeannine brings to the firm her invaluable legal knowledge and sharp litigation skills while also offering the insights, experience, and wisdom from her nearly two decades in public policy and consumer advocacy,” said firm Chairman Michael D. Hausfeld. “The combination brings excellent results to the firm, our clients, and the legal community. We are pleased to count her among our partners.” 

A magna cum laude graduate of the Georgetown University Law Center, where she served on the Georgetown Law Journal, and a former clerk to the Honorable Cynthia M. Rufe (E.D. Pa.), Ms. Kenney is admitted to practice in the District of Columbia and the Commonwealth of Pennsylvania.

NOTES TO EDITORS

About Hausfeld

Hausfeld is a leading global law firm with offices in Berlin, Boston, Brussels, London, New York, Philadelphia, San Francisco, and Washington, DC. The firm has a broad range of complex litigation expertise, particularly in antitrust/competition, financial services, sports and entertainment, environmental, mass torts, consumer protection, and human rights matters, often with an international dimension. Hausfeld aims to achieve the best possible results for clients through its practical and commercial approach, avoiding litigation where feasible, yet litigating robustly when necessary. Hausfeld’s extensive experience with alternative and innovative fee models offers clients a diverse menu of engagement options and maximum flexibility in terms of managing their cost exposure. Hausfeld is the only claimant firm to be ranked by the Legal 500 and Chambers & Partners as a top tier firm in private enforcement of antitrust/competition law in both the United States and the United Kingdom.

For more information about the firm, including recent trial victories and landmark settlements, please visit: www.hausfeld.com .

For further information or to arrange interviews please contact: Deborah Schwartz Media Relations (240) 355-8838 deborah@mediarelationsinc.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 135

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 180

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 235

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

Kulicke & Soffa Announces Conference Call for Fiscal Results

Updated Category News Views 122

Kulicke & Soffa Schedules Conference Call Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC), a leading name in semiconductor assembly technology, has announced a conference call to discuss its third fiscal quarter financial results and business outlook. The call is set for a future date, highlighting the company's commitment to transparency and communication with its...

Continue Reading
ARMOUR Residential REIT Launches Major Stock Offering for Growth

Updated Category News Views 162

ARMOUR Residential REIT Enters Public Stock Offering ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) has officially announced an underwritten public offering of 18,500,000 shares of common stock. The company is poised to grant underwriters an additional option to purchase up to 2,775,000 shares, making this a significant move for ARMOUR as it aims to enhance its...

Continue Reading
Celebrate Mother's Day with a Unique Brunch at Cannon + Belle

Updated Category News Views 195

Cannon + Belle Offers a Memorable Mother's Day Brunch Cannon + Belle at Hilton Austin is excited to announce an elevated Mother's Day brunch that promises to create unforgettable memories. This year, the restaurant will be hosting a special brunch event aimed at honoring mothers and all they do. With an impressive menu curated by the talented Chef Gereamy Cater, guests...

Continue Reading
Figma's Shares Surge in IPO But Valuation Remains a Concern

Updated Category News Views 244

Figma's Impressive IPO Performance Figma Inc. (NYSE: FIG) has captured significant investor attention following its explosive debut in the stock market. After launching its initial public offering, the company's shares skyrocketed by over 250%, marking a remarkable milestone for the firm. The stock began trading at a price of $33 per share, leading to approximately $1.2...

Continue Reading
Journey Medical Corporation's Emrosi Launch for Rosacea Relief

Updated Category News Views 215

Journey Medical Corporation Introduces Emrosi for Rosacea Treatment Journey Medical Corporation, a key player in the dermatological pharmaceutical industry, has recently launched Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules), designed for the effective treatment of rosacea. The product, featuring a unique formulation of 10 mg immediate release and...

Continue Reading